19 June 2026

Latham & Watkins Advises cAMPfield on US$180 Million Series A

Advising firms

4 lawyers named

Lawyer	Firm	Seniority	Practice	Office
Matt Bush Lead	Latham & Watkins LLP	Partner	corporate	San Diego
Christian Hollweg	Latham & Watkins LLP	Partner	corporate	San Diego
Alex Stuart-Lovell	Latham & Watkins LLP	Associate	corporate	Not stated
Robert Yeh	Latham & Watkins LLP	Counsel	licensing	San Diego

1 more lawyer on this deal. Register free to see the full deal team, with seniority, practice and office.

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated value: USD 180m (US$180 million)
What the figure measures: Fund size
Client: cAMPfield Therapeutics, Inc.Issuer
Counterparties: Frazier Life Sciences (Investor)
Deep Track Capital (Investor)
Forbion (Investor)
Abingworth (Investor)
Venrock (Investor)
Longitude Capital (Investor)
Novo Holdings (Investor)
RA Capital (Investor)